COO
The Cooper Companies, Inc. · Healthcare · Medical - Instruments & Supplies
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 149 | +2 | 133.62M | $9.60B | +8 | −7 |
| Q1 2026 | 151 | +1 | 132.75M | $9.51B | +6 | −6 |
| Q4 2025 | 149 | -1 | 147.94M | $12.12B | +1 | −1 |
| Q3 2025 | 22 | -1 | 84.49M | $5.79B | — | −2 |
| Q2 2025 | 21 | 0 | 75.38M | $5.36B | +1 | −1 |
| Q1 2025 | 18 | -4 | 34.09M | $2.87B | — | −4 |
| Q4 2024 | 22 | +2 | 30.60M | $2.81B | +2 | — |
| Q3 2024 | 19 | +3 | 19.38M | $2.14B | +3 | — |
| Q2 2024 | 16 | — | 16.68M | $1.46B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 4.81M | — | $420.25M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 4.75M | — | $413.41M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (passive) | 2.29M | — | $199.70M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 1.63M | — | $141.97M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 5 | Point72 Asset Management ✦ | 937.81K | — | $81.87M | 0.3% | n/c | 1 | SEC ↗ |
| 6 | Marshall Wace ✦ | 783.90K | — | $68.43M | 0.1% | n/c | 1 | SEC ↗ ×3 |
| 7 | Millennium Management ✦ | 460.81K | — | $40.23M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 360.02K | — | $31.43M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 9 | T. Rowe Price ✦ | 283.40K | — | $24.74M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 10 | Adage Capital Partners ✦ | 190.66K | — | $16.64M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Fisher Asset Management ✦ | 60.53K | — | $5.28M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | GAMCO Investors ✦ | 44.00K | — | $3.84M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Bridgewater Associates ✦ | 41.97K | — | $3.66M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Wellington Management ✦ | 32.06K | — | $2.80M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 15 | AQR Capital Management ✦ | 9.39K | — | $820,183 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 16 | Two Sigma Investments ✦ | 3.23K | — | $282,241 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 664 holders, 203.43M shares, $13.35B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
Director · 10.00K sh @ 54.93 · $549,320
Director · 10.00K sh @ 53.91 · $539,150
Director · 3.00K sh @ 54.29 · $162,870
Director · 7.00K sh @ 54.11 · $378,770
Director · 4.70K sh @ 53.18 · $250,000
Open-market sales (S)
No open-market insider sales in our coverage window.
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology